ETX0282
Product Specifications
CAS Number
2209871-83-8
Target
Others
Related Pathways
Others
Bioactivity
ETX0282 is an orally available, broad spectrum inhibitor of class A and C β-lactamases. Entasis is developing ETX0282 in combination with cefpodoxime proxetil, an orally available cephalosporin approved for treatment of a variety of bacterial infections.
Smiles
O([C@@H](C(OC(C)C)=O)F)N1[C@]2(C[N@@](C1=O)[C@H](C(N)=O)C=C2C)[H]
Molecular Formula
C13H18FN3O5
Molecular Weight
315.3
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2014101-01 0.1 mL
FITC-linked Antibody to Hepatocyte Growth Factor (HGF)
Sign In for Pricing
View Details MBS2014101-02 0.2 mL
FITC-linked Antibody to Hepatocyte Growth Factor (HGF)
Sign In for Pricing
View Details MBS2014101-03 0.5 mL
FITC-linked Antibody to Hepatocyte Growth Factor (HGF)
Sign In for Pricing
View Details MBS2014101-04 1 mL
FITC-linked Antibody to Hepatocyte Growth Factor (HGF)
Sign In for Pricing
View Details MBS2014101-05 5 mL
FITC-linked Antibody to Hepatocyte Growth Factor (HGF)
Sign In for Pricing
View Details